#PartialReprogramming
The Phase 1 trial of ER-100, which activates Yamanaka factors in the eye, did not cause serious adverse events in three participants. Early visual field signals were observed in two of the three patients with open-angle glaucoma.

#PartialReprogramming #ER100 #Glaucoma
Two of three glaucoma patients showed early visual-field signals
Source: Longevity.Technology
realfeedapp.com
October 9, 2026 at 6:00 AM
Sharing a visualization from a methodological exercise on partial reprogramming kinetics that may be of interest to colleagues working on in vivo epigenetic rejuvenation paradigms.

#PartialReprogramming #YamanakaFactors #EpigeneticRejuvenation #AgingBiology #InVivoReprogramming
July 10, 2026 at 5:03 PM
Sharing a visualization developed for didactic and exploratory purposes, addressing the temporal dynamics of OSKM-mediated reprogramming in somatic cells.

#CellularReprogramming #YamanakaFactors #iPSC #Pluripotency #Epigenetics #Senescence #PartialReprogramming #SystemsBiology
June 28, 2026 at 5:03 PM
Transient OSKM induction dynamics in aged fibroblasts: relative transcript abundance over a 6-day doxycycline pulse-chase.

#PartialReprogramming #YamanakaFactors #CellularRejuvenation #EpigeneticReprogramming #OSKM #AgingBiology #TranscriptionalDynamics #SystemsBiology
June 26, 2026 at 5:01 PM
Epigenetic age reversal kinetics under partial versus complete Yamanaka factor-mediated reprogramming

Transient induction of OCT4, SOX2, and KLF4 (OSK) or the complete OSKM cassette.

#EpigeneticReprogramming #YamanakaFactors #PartialReprogramming #EpigeneticClock #OSK #Rejuvenation #AgingBiology
May 29, 2026 at 5:00 PM